Literature DB >> 18202817

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Johannes Attems1, Florían Lauda, Kurt A Jellinger.   

Abstract

In a retrospective study of a consecutive autopsy series of 2060 elderly subjects (mean age 78.5 +/- 6.8 SD years), sporadic cerebral amyloid angiopathy (CAA) of various degrees was detected in 73.2% and in 98.5% of autopsy-confirmed cases of typical (plaque and tangle) Alzheimer disease (AD). Spontaneous (non-traumatic) intracerebral hemorrhages (ICH) (excluding microbleeds) were seen in 5.6% of the total cohort and in 7.2% of definite AD cases; CAA was found in 49% of brains without and in 48.7% with ICH which was not significantly different. The latter groups showed a significantly higher frequency of severe degrees of CAA than those without ICH (80.4 vs 30.9%, p < 0.001). Patients with CAA were older than those without CAA, showing a higher frequency of clinical dementia and pathologically confirmed AD, but signs of hypertension (history and/or autopsy) were seen in 41 and 33.6% of these cases, respectively, compared to 70-75% in patients with non-CAA related ICHs. CAA-related ICH much more frequently involved cerebral lobes or hemispheres, while non-CAA related lesions were more often located in basal ganglia and brainstem. The data of a lower prevalence of CAA in cases without than with ICH, but a similar prevalence of ICH with and without CAA do not support the concept that CAA represents the most evident risk factor for ICH in the aged. While severe degrees of CAA were indeed associated with ICH, the general prevalence of large ICH in this autopsy cohort was much higher in cases without CAA, probably due to other risk factors including hypertension, which was documented in around 40% of cases with CAA-related ICH. APOE epsilon3/4 and epsilon4/4 were significantly more frequent in AD (n = 163) than in age-matched controls (n = 47) and were associated with more severe degrees of CAA, but no general genotyping in ICHs with and without CAA was performed. Hence, the role of APOE in the pathogenesis of ICH with and without CAA needs further elucidation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202817     DOI: 10.1007/s00415-008-0674-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  57 in total

Review 1.  Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.

Authors:  Hans-Christian Koennecke
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

2.  Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.

Authors:  H S Cho; B T Hyman; S M Greenberg; G W Rebeck
Journal:  J Neuropathol Exp Neurol       Date:  2001-04       Impact factor: 3.685

3.  Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration.

Authors:  C L Sudlow; C P Warlow
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

Review 4.  Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J A Nicoll
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

5.  The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J A Nicoll; J Stewart; J W Ironside; D M Mann; S Love; D I Graham; D Dewar
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

6.  APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.

Authors:  J A Nicoll; M O McCarron
Journal:  Amyloid       Date:  2001-07       Impact factor: 7.141

7.  Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population.

Authors:  T Seifert; A Lechner; E Flooh; H Schmidt; R Schmidt; F Fazekas
Journal:  Cerebrovasc Dis       Date:  2006-01-27       Impact factor: 2.762

Review 8.  Cerebral amyloid angiopathy and dementia.

Authors:  J Tian; J Shi; D M A Mann
Journal:  Panminerva Med       Date:  2004-12       Impact factor: 5.197

9.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

Review 10.  Brain parenchymal and microvascular amyloid in Alzheimer's disease.

Authors:  H V Vinters; Z Z Wang; D L Secor
Journal:  Brain Pathol       Date:  1996-04       Impact factor: 6.508

View more
  24 in total

Review 1.  Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications.

Authors:  Cumara B O'Carroll; Maria I Aguilar
Journal:  Neurohospitalist       Date:  2015-07

Review 2.  [Amyloidoses in neuropathology].

Authors:  S Prokop; W Stenzel; H H Goebel; F L Heppner
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

3.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Authors:  E Kövari; F R Herrmann; P R Hof; C Bouras
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

Review 4.  Long-term neprilysin inhibition - implications for ARNIs.

Authors:  Duncan J Campbell
Journal:  Nat Rev Cardiol       Date:  2016-12-15       Impact factor: 32.419

5.  Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy.

Authors:  Oliver J Standring; Jacob Friedberg; Yorghos Tripodis; Alicia S Chua; Jonathan D Cherry; Victor E Alvarez; Bertrand R Huber; Weiming Xia; Jesse Mez; Michael L Alosco; Raymond Nicks; Ian Mahar; Morgan J Pothast; Hannah M Gardner; Gaoyuan Meng; Joseph N Palmisano; Brett M Martin; Brigid Dwyer; Neil W Kowall; Robert C Cantu; Lee E Goldstein; Douglas I Katz; Robert A Stern; Ann C McKee; Thor D Stein
Journal:  Acta Neuropathol       Date:  2019-06-10       Impact factor: 17.088

Review 6.  Imaging small vessel-associated white matter changes in aging.

Authors:  D H Salat
Journal:  Neuroscience       Date:  2013-12-06       Impact factor: 3.590

7.  Pathological examination of cerebral amyloid angiopathy in patients who underwent removal of lobar hemorrhages.

Authors:  Chien-Min Lin; Hidetaka Arishima; Ken-Ichiro Kikuta; Hironobu Naiki; Ryuhei Kitai; Toshiaki Kodera; Ken Matsuda; Norichika Hashimoto; Makoto Isozaki; Kenzo Tsunetoshi; Hiroyuki Neishi; Yoshifumi Higashino; Ayumi Akazawa; Hiroshi Arai; Shinsuke Yamada
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

8.  Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.

Authors:  Willa D Brenowitz; Peter T Nelson; Lilah M Besser; Katherine B Heller; Walter A Kukull
Journal:  Neurobiol Aging       Date:  2015-07-08       Impact factor: 4.673

Review 9.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

10.  Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Dietmar R Thal; Thomas Arzberger; Nenad Bogdanovic; Safa Al-Sarraj; Istvan Bodi; Susan Boluda; Orso Bugiani; Charles Duyckaerts; Ellen Gelpi; Stephen Gentleman; Giorgio Giaccone; Manuel Graeber; Tibor Hortobagyi; Romana Höftberger; Paul Ince; James W Ironside; Nikolaos Kavantzas; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; David Meyronet; Camelia Monoranu; Tatjana Nilsson; Piero Parchi; Efstratios Patsouris; Maria Pikkarainen; Tamas Revesz; Annemieke Rozemuller; Danielle Seilhean; Walter Schulz-Schaeffer; Nathalie Streichenberger; Stephen B Wharton; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2009-02-01       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.